Mentions
Extended reach
Total likes
Video views
AI synopsis
The analysis reveals a generally positive and engaged response, with references to the publication as a noteworthy contribution to synthetic virology and mentions of ongoing impact, reflecting both support and the perceived importance of this research for improving oncolytic treatments.
Most discussions endorse the publication, highlighting its significance in advancing oncolytic virus therapy safety and efficacy.
Users are highly interested, as shown by enthusiastic comments and recognition of the work's importance.
Posts reflect thoughtful engagement, with some sharing specific details and expressing support for the research.
The discussions suggest the publication's potential to influence future research and clinical applications in cancer therapy.
Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies | Nature Communications https://t.co/vPINa5c9Re
Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies https://t.co/7Up6QQFVis
Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies | Nature Communications https://t.co/BB9V341qgP
Congratulations to @chembioBryan for contributing to the recent publication in @NatureComms - "Synthetic Virology Approaches to Improve the Safety and Efficacy of Oncolytic Virus Therapies" - that has already begun to find its way in the world. https://t.co/Zv0ArHJWFO
RT @dr_alphalyrae: Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies | Nature Communications ht…
RT @Ahmad_B_Mahmoud: Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies | Nature Communications…
This study focuses on improving oncolytic virus therapies, specifically vaccinia virus vectors, by developing gene switches that allow precise regulation of viral gene expression, enhancing safety and efficacy.
This study explores improving oncolytic virus therapies by developing drug-controlled gene switches that enable precise regulation of viral gene expression, improving safety and effectiveness for cancer treatment.
Congratulations to @chembioBryan for contributing to the recent publication in @NatureComms - "Synthetic Virology Approaches to Improve the Safety and Efficacy of Oncolytic Virus Therapies" - that has already begun to find its way in the world. https://t.co/Zv0ArHJWFO
RT @Ahmad_B_Mahmoud: Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies | Nature Communications…
Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies | Nature Communications https://t.co/BB9V341qgP
RT @dr_alphalyrae: Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies | Nature Communications ht…
Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies https://t.co/YcL1yEgfsY https://t.co/j2VPSbqEl7
Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies | Nature Communications https://t.co/vPINa5c9Re
RT @RQpdPyjf1VbJKTe: Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies https://t.co/7Up6QQFVis
Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies https://t.co/7Up6QQFVis
Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies https://t.co/hcwYejDbHd https://t.co/927B3NxAYf